Literature DB >> 24117196

The opioid methadone induces a local anaesthetic-like inhibition of the cardiac Na⁺ channel, Na(v)1.5.

V Schulze1, C Stoetzer, A O O'Reilly, E Eberhardt, N Foadi, J Ahrens, F Wegner, A Lampert, J de la Roche, A Leffler.   

Abstract

BACKGROUND AND
PURPOSE: Treatment with methadone is associated with severe cardiac arrhythmias, a side effect that seems to result from an inhibition of cardiac hERG K⁺ channels. However, several other opioids are inhibitors of voltage-gated Na⁺ channels. Considering the common assumption that an inhibition of the cardiac Na⁺ channel Na(v)1.5, is the primary mechanism for local anaesthetic (LA)-induced cardiotoxicity, we hypothesized that methadone has LA-like properties leading to a modulation of Na(v)1.5 channels. EXPERIMENTAL APPROACH: The whole-cell patch clamp technique was applied to investigate the effects of methadone on wild-type and mutant human Na(v)1.5 channels expressed in HEK293 cells. A homology model of human Na(v)1.5 channels was used to perform automated ligand-docking studies. KEY
RESULTS: Methadone inhibited Na(v)1.5 channels in a state-dependent manner, that is, tonic block was stronger with inactivated channels than with resting channels and a use-dependent block at 10 Hz. Methadone induced a concentration-dependent shift of the voltage dependency of both fast and slow inactivation towards more hyperpolarized potentials, and impaired recovery from fast and slow inactivation. The LA-insensitive mutants N406K and F1760A exhibited reduced tonic and use-dependent block by methadone, and docking predictions positioned methadone in a cavity that was delimited by the residue F1760. Dextromethadone and levomethadone induced discrete stereo-selective effects on Na(v)1.5 channels. CONCLUSIONS AND IMPLICATIONS: Methadone interacted with the LA-binding site to inhibit Na(v)1.5 channels. Our data suggest that these channels are a hitherto unrecognized molecular component contributing to cardiac arrhythmias induced by methadone.
© 2013 The British Pharmacological Society.

Entities:  

Keywords:  Nav1.5; cardiac toxicity; local anaesthetic; methadone; sodium channel

Mesh:

Substances:

Year:  2014        PMID: 24117196      PMCID: PMC3904262          DOI: 10.1111/bph.12465

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Block of human heart hH1 sodium channels by the enantiomers of bupivacaine.

Authors:  C Nau; S Y Wang; G R Strichartz; G K Wang
Journal:  Anesthesiology       Date:  2000-10       Impact factor: 7.892

2.  Local anesthetic-like inhibition of voltage-gated Na(+) channels by the partial μ-opioid receptor agonist buprenorphine.

Authors:  Andreas Leffler; Georg Frank; Katrin Kistner; Florian Niedermirtl; Wolfgang Koppert; Peter W Reeh; Carla Nau
Journal:  Anesthesiology       Date:  2012-06       Impact factor: 7.892

3.  Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents.

Authors:  Alexander N Katchman; Kelly A McGroary; Michael J Kilborn; Craig A Kornick; Paolo L Manfredi; Raymond L Woosley; Steven N Ebert
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

4.  Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole.

Authors:  C W Clarkson; L M Hondeghem
Journal:  Anesthesiology       Date:  1985-04       Impact factor: 7.892

5.  d-Methadone is antinociceptive in the rat formalin test.

Authors:  N Shimoyama; M Shimoyama; K J Elliott; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1997-11       Impact factor: 4.030

6.  Use-dependent block by lidocaine but not amitriptyline is more pronounced in tetrodotoxin (TTX)-Resistant Nav1.8 than in TTX-sensitive Na+ channels.

Authors:  Andreas Leffler; Anne Reiprich; Durga P Mohapatra; Carla Nau
Journal:  J Pharmacol Exp Ther       Date:  2006-09-27       Impact factor: 4.030

Review 7.  Models and mechanisms of local anesthetic cardiac toxicity: a review.

Authors:  John F Butterworth
Journal:  Reg Anesth Pain Med       Date:  2010 Mar-Apr       Impact factor: 6.288

8.  Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts.

Authors:  J W de Vos; P J Geerlings; W van den Brink; J G Ufkes; H van Wilgenburg
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

9.  The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine.

Authors:  K Kristensen; C B Christensen; L L Christrup
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

10.  Stereoselective Inhibition of the hERG1 Potassium Channel.

Authors:  Liliana Sintra Grilo; Pierre-Alain Carrupt; Hugues Abriel
Journal:  Front Pharmacol       Date:  2010-11-22       Impact factor: 5.810

View more
  7 in total

1.  Determination of the unbound fraction of R- and S-methadone in human brain.

Authors:  Xiulu Ruan; Ken F Mancuso; Alan David Kaye
Journal:  Int J Legal Med       Date:  2016-07-25       Impact factor: 2.686

2.  Activity-dependent depression of neuronal sodium channels by the general anaesthetic isoflurane.

Authors:  K Purtell; K J Gingrich; W Ouyang; K F Herold; H C Hemmings
Journal:  Br J Anaesth       Date:  2015-07       Impact factor: 9.166

3.  The opioid oxycodone use-dependently inhibits the cardiac sodium channel NaV 1.5.

Authors:  Jannis E Meents; Krisztina Juhasz; Sonja Stölzle-Feix; Vera Peuckmann-Post; Roman Rolke; Angelika Lampert
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

4.  Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics.

Authors:  C Stoetzer; T Doll; T Stueber; C Herzog; F Echtermeyer; F Greulich; C Rudat; A Kispert; F Wegner; A Leffler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-22       Impact factor: 3.000

5.  Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.

Authors:  Carsten Stoetzer; Svenja Reuter; Thorben Doll; Nilufar Foadi; Florian Wegner; Andreas Leffler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-15       Impact factor: 3.000

6.  Block of Voltage-Gated Sodium Channels by Atomoxetine in a State- and Use-dependent Manner.

Authors:  Karl Josef Föhr; Ariadni Nastos; Michael Fauler; Thomas Zimmer; Bettina Jungwirth; David Alexander Christian Messerer
Journal:  Front Pharmacol       Date:  2021-02-25       Impact factor: 5.810

7.  Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.

Authors:  Phu N Tran; Jiansong Sheng; Aaron L Randolph; Claudia Alvarez Baron; Nicolas Thiebaud; Ming Ren; Min Wu; Lars Johannesen; Donna A Volpe; Dakshesh Patel; Ksenia Blinova; David G Strauss; Wendy W Wu
Journal:  PLoS One       Date:  2020-11-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.